High blood pressure may seem like something that only adults get, but children can develop it too — and it can pose serious risks to their hearts, brains and lives. While medications may help some children, a new study shows that for kids with a rare but especially dangerous form of hypertension, surgery is the best option.
Recent studies show promise for significantly reducing vascular aging by inactivating TNF?, which has been linked to blood vessel dysfunction and cell death. The related report by Csiszar et al., “Vasculoprotective effects of anti-TNF? treatment in aging,” appears in the January issue of The American Journal of Pathology.
The incidence of stroke in the US over the past 50 years has declined, although the severity of stroke has not, according to a study in the December 27 issue of JAMA.
In a new study, scientists at the Scripps Research Institute have described for the first time a glucose-activated sensor that acts as a switch to decrease production of endogenous glucose in the liver, and increase conversion of glucose to fat for storage in adipose tissue. This dual action makes the sensor, Liver X Receptor, a potential target for new therapies aimed at obesity and diabetes. The research may also have implications for heart disease and stroke.
Methamphetamine use may be associated with increased risks of major neck artery tears and stroke, according to an article published in the December 26, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
The Lancet Neurology published a new study saying women are at higher inherited risk for the most common type of stroke than men. The new study found that women who had strokes were 40 percent more likely to have at least one close relative who suffered a stroke than were men with strokes. Having a mother who had a stroke was 80 percent more common in women stroke patients than in men.
People with low levels of LDL cholesterol are more likely to have Parkinson’s disease than people with high LDL levels, according to University of North Carolina at Chapel Hill researchers.
Agalsidease-beta therapy for Fabry disease slowed progression of kidney, heart and nervous system complications and death compared to placebo, a new study found.
Breast Cancer Action (BCA) released a report today, in conjunction with a poster presentation at the San Antonio Breast Cancer Symposium, on the side effects of aromatase inhibitors (AIs). The report, “Side Effects Revealed: Women’s Experiences with Aromatase Inhibitors,” analyzes 612 women’s responses to an online survey of the drugs’ side effects.
Biophan Technologies, Inc., a developer of next-generation medical technology, in conjunction with MYOTECH, LLC, recently presented results of animal studies that indicate the potential of the MYO-VAD, a cardiac support system to significantly improve the treatment of heart failure. The MYO-VAD restores cardiac output on an arrested or weak heart. The device can be implanted in approximately three minutes.